Awarded
Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.
£76,536
UNIVERSITY OF NOTTINGHAM (THE)MEDICINES DISCOVERY CATAPULT SERVICES LIMITED
services
Contract Details
- Tender Value
- £76,536
- Stage
- Awarded
- Published
- Awarded
Timeline
Awarded
Start
End
Disclosed
Description
The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform.
Related Contracts
From This Buyer
From This Supplier
- MDCS - Winter Capacity (21/22)
£127,800,000 ·
- Winter Surge Capacity (21/22)
£59,340,000 ·
In This Category
Ref: b7fe11c2-b9bc-4f06-8d38-f5d56d677deb-609355 · Sourced from Contracts Finder
View source notice